BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7913604)

  • 1. Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells.
    Safa AR; Roberts S; Agresti M; Fine RL
    Biochem Biophys Res Commun; 1994 Jul; 202(1):606-12. PubMed ID: 7913604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
    Politi PM; Arnold ST; Felsted RL; Sinha BK
    Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B; Prichard RK; Georges E
    Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K; Tsuruo T
    Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha 1-adrenergic photoaffinity probe [125I]arylazidoprazosin binds to a specific peptide of P-glycoprotein in multidrug-resistant cells.
    Safa AR; Agresti M; Tamai I; Mehta ND; Vahabi S
    Biochem Biophys Res Commun; 1990 Jan; 166(1):259-66. PubMed ID: 1967938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
    Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
    Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
    Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
    Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
    Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
    Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
    Safa AR; Agresti M; Bryk D; Tamai I
    Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.
    Garrigos M; Belehradek J; Mir LM; Orlowski S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1034-41. PubMed ID: 7902705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines.
    Qian XD; Beck WT
    Cancer Res; 1990 Feb; 50(4):1132-7. PubMed ID: 1967551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of multidrug-resistant pituitary tumor cells.
    Nelson EJ; Hinkle PM
    Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin).
    Ganapathi R; Hercbergs A; Grabowski D; Ford J
    Cancer Res; 1993 Jul; 53(14):3262-5. PubMed ID: 8100737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance.
    Kang Y; Perry RR
    Cancer Res; 1993 Jul; 53(13):3040-5. PubMed ID: 8100483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between multidrug resistance, hypersensitivity to resistance modifiers and cell volume in Chinese hamster ovary cells.
    Vickers SE; Stow MW; Warr JR
    Cell Biol Int; 1993 May; 17(5):477-85. PubMed ID: 8101756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal secretion of vinblastine, vincristine and colchicine in vivo.
    de Lannoy IA; Mandin RS; Silverman M
    J Pharmacol Exp Ther; 1994 Jan; 268(1):388-95. PubMed ID: 7905530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
    Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.
    Foxwell BM; Mackie A; Ling V; Ryffel B
    Mol Pharmacol; 1989 Oct; 36(4):543-6. PubMed ID: 2572960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
    Safa AR
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.